Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe diseaseYildirim Dogan, Niek P. van Til, Mary E. Jacobs et al.|Molecular Therapy — Methods & Clinical Development|2022Cited by 16
Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestationsJohn K. Yoon, Niek P. van Til, Jeffrey W. Schindler et al.|Molecular Therapy|2024Cited by 5
Preclinical lentiviral vector-mediated hematopoietic stem and progenitor cell gene therapy corrects Pompe disease-related muscle and neurological manifestationsJohn K. Yoon, Niek P. van Til, Jeffrey W. Schindler et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 0